Article ID Journal Published Year Pages File Type
8740654 Journal of Infection and Chemotherapy 2018 7 Pages PDF
Abstract
In conclusion, this study showed that filgrastim biosimilar 2 has a similar safety profile and comparable effects to the original G-CSF product in the real world clinical setting.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Applied Microbiology and Biotechnology
Preview
Clinical safety and efficacy of “filgrastim biosimilar 2” in Japanese patients in a post-marketing surveillance study
Authors
, , ,